Close Menu

NEW YORK – Ginkgo Bioworks today announced a $290 Series E financing round from new and prior investors.

New investors include funds and accounts advised by T. Rowe Price Associates. All major existing investors participated in the round, Ginkgo said. The firm said it would use the funding to grow its cell programming platform.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New research shows that scientists need to do a better job of including a wider diversity of African genomes in their analyses, STAT says.

A new paper in Science shows that men are still winning a large majority of the most sought-after NIH grants.

Nature Research and the Estée Lauder Companies are awarding efforts to encourage girls to pursue careers in the STEM fields.

In Science this week: beneficial genetic variants inherited from archaic Neanderthal and Denisovan hominins, and more.